The 2024 edition of the Transcatheter Cardiovascular Therapeutics (TCT) conference once again highlighted significant innovations in cardiovascular care. This year’s event in Washington, D.C., featured company updates on all types of technologies, including heart valves, access and closure devices, drug-eluting implants, intravascular lithotripsy (IVL), renal denervation (RDN) and more. Some of the biggest names in […]
TCT 2024
Boston Scientific Acurate neo2 TAVR misses primary endpoint in IDE trial
Boston Scientific (NYSE:BSX) today announced that a study of its Acurate neo2 aortic valve system missed its primary endpoint. The ACURATE IDE study evaluated Acurate neo2, a transcatheter aortic valve replacement (TAVR) system, in the treatment of patients with severe, symptomatic aortic stenosis at low, intermediate, high and extreme risk of open-heart surgery. Investigators presented […]
Edwards study shows superiority of Evoque tricuspid valve replacement
Edwards Lifesciences (NYSE:EW) today announced data highlighting the superiority of its Evoque system compared to medical therapy alone. The TRISCEND II evaluated the Evoque transcatheter tricuspid valve replacement (TTVR) system with optimal medical therapy (OMT) compared to OMT alone with 2:1 randomization. It found that Evoque demonstrated superiority compared to OMT alone at the one-year […]
Inari Medical’s FlowTriever meets primary endpoint in pulmonary embolism trial
Inari Medical (Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system. The company designed its FlowTriever for device retrieval and aspiration. The system treats pulmonary embolism (PE). FlowTriever non-surgically removes clots from peripheral blood vessels. Its uses include treatment for PE and clots in transit in the right atrium. It received […]
Elixir Medical has positive data for drug-eluting bioadaptive implant
Elixir Medical announced positive data demonstrating the benefit of its DynamX coronary bioadaptor system in target lesion failure (TLF). Data highlighted the success of DynamX compared to Medtronic’s Resolute Onyx zotarolimus drug-eluting stent (DES). The study looked at complex patient populations within the INFINITY-SWEDEHEART randomized controlled trial. Data included an analysis of patients with acute […]
Vivasure reports positive PerQseal closure device study results
Vivasure Medical reported positive data from an FDA investigational device exemption (IDE) pivotal study evaluating its PerQseal closure device system. Initial results came from the PATCH pivotal study evaluating the safety and efficacy of PerQseal. Investigators presented findings at Transcatheter Cardiovascular Therapeutics (TCT) 2024 in Washington, D.C. Galway, Ireland-based Vivasure designed the latest-generation PerQseal Elite […]
Cardiawave has positive data for ultrasound tech that treats calcified aortic stenosis
Cardiawave said its device for the treatment of severe symptomatic calcific aortic stenosis (CAS) met the primary endpoint in a pivotal study. The investigational Valvosoft non-invasive ultrasound therapy (NIUT) device improved or stabilized heart failure symptoms for 80.5% of patients. It substantially improved hemodynamics and patient quality of life six months after treatment, according to […]
MitrAssist has positive data on new transthoracic heart valve
MitrAssist Lifesciences announced clinical results for its new transthoracic heart valve (THV) system for TAVI procedures. Data demonstrated the potential to improve outcomes for patients suffering from severe symptomatic aortic stenosis, according to a news release. The company reported findings at Transcatheter Cardiovascular Therapeutics (TCT) 2024 in Washington, D.C. MitrAssist designed the Sikelia system for […]
Shockwave Medical completes enrollment in all-female IVL study
Shockwave Medical, now part of Johnson & Johnson MedTech, has completed enrollment for its Empower CAD all-female study on percutaneous coronary intervention (PCI) in complex calcific coronary disease. The Shockwave study aims to confirm the benefits of coronary intravascular lithotripsy (IVL) in women. Co-principal investigator Dr. Margaret McEntegart, director of Complex PCI and CTO programs […]
Medtronic reports positive long-term renal denervation outcomes
Medtronic (NYSE:MDT) today announced new, long-term study data further supporting its Symplicity Spyral renal denervation (RDN) system. Symplicity Spyral delivers radiofrequency energy to nerves near kidneys in a minimally invasive procedure to treat hypertension. These nerves can become overactive and contribute to high blood pressure. The RDN system holds approval for commercial use in more […]
HeartFlow data supports AI plaque analysis
HeartFlow announced positive seven-year data supporting the use of its AI-enabled fractional flow reserve computed tomography (FFRCT) and Plaque Analysis. This study assessed long-term risk of coronary artery disease (CAD) in clinically stable, symptomatic patients. Outcomes showed that the HeartFlow platform provides clinicians with the insights needed to anticipate and mitigate adverse events. That includes myocardial infarctions […]